BlackRock Amends IDEAYA Biosciences Stake, Maintains Passive Position
Ticker: IDYA · Form: SC 13G/A · Filed: Jan 25, 2024 · CIK: 1676725
| Field | Detail |
|---|---|
| Company | Ideaya Biosciences, Inc. (IDYA) |
| Form Type | SC 13G/A |
| Filed Date | Jan 25, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investing
TL;DR
**BlackRock still owns a big chunk of IDEAYA Biosciences, signaling confidence.**
AI Summary
BlackRock Inc. filed an amended SC 13G/A on January 25, 2024, disclosing its ownership of IDEAYA Biosciences Inc. common stock as of December 31, 2023. This amendment, number 2, indicates BlackRock continues to hold a significant passive stake in IDEAYA Biosciences. This matters to investors because BlackRock, a major institutional investor, maintaining its position signals continued confidence in IDEAYA's long-term prospects, potentially influencing other investors.
Why It Matters
BlackRock's continued significant, albeit passive, ownership in IDEAYA Biosciences Inc. suggests a vote of confidence from a major institutional investor, which can positively influence market perception and investor sentiment.
Risk Assessment
Risk Level: low — This filing is a routine update from a passive institutional investor and does not indicate any immediate risks or significant changes in company control.
Analyst Insight
Investors should note BlackRock's continued passive stake as a sign of institutional confidence, but this filing alone doesn't warrant immediate action. It's a data point to consider alongside other fundamental and technical analysis.
Key Players & Entities
- BlackRock Inc. (company) — the institutional investor filing the SC 13G/A
- IDEAYA Biosciences, Inc. (company) — the subject company whose stock is being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 25, 2024 (date) — the filing date of the SC 13G/A
- 45166A102 (other) — the CUSIP number for IDEAYA Biosciences Inc. Common Stock
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G, filed under the Securities Exchange Act of 1934.
Who is the 'subject company' in this filing?
The subject company is IDEAYA Biosciences, Inc., identified by CIK 0001676725 and CUSIP 45166A102 for its Common Stock.
Who is the 'filed by' entity in this document?
The entity that filed this document is BlackRock Inc., identified by CIK 0001364742.
What was the 'Date of Event Which Requires Filing of this Statement'?
The date of the event which requires the filing of this statement was December 31, 2023.
Which rule under the Securities Exchange Act of 1934 is designated for this filing?
This Schedule is filed pursuant to Rule 13d-1(b), as indicated by the 'X' in the appropriate box.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 25, 2024 regarding IDEAYA Biosciences, Inc. (IDYA).